APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Microbiome

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.

An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.

Selected research

Market Structure

Global Human Microbiome Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025192 pages

Choose your research edition.

Industry ResearchHuman Microbiome Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Microbiome Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Human Microbiome Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Microbiome Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Microbiome Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.

An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.

Read the full market overview

At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.

Report Includes

This report provides an overview of the global Human Microbiome market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Microbiome and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Microbiome revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Human Microbiome market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Microbiome Segment by Company

Vedanta

Seres Therapeutics

Second Genome

Rebiotix

ActoGeniX

Enterome BioScience

AvidBiotics

4D Pharma Research Ltd

Enterologics

Metabogen

Metabiomics

Ritter Pharmaceuticals

Osel

Symberix

Miomics

Symbiotix Biotherapies

MicroBiome Therapeutics LLC

Human Microbiome Segment by Type

Gastrointestinal Tract Human Micobiome

Urogenital Tract Human Micobiome

Others

Human Microbiome Segment by Application

Treatment

Diagnosis

Human Microbiome Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Microbiome market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Microbiome and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Microbiome.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Human Microbiome in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Microbiome industry.

Chapter 3: Detailed analysis of Human Microbiome companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Microbiomerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Gastrointestinal Tract Human Micobiome Table 3. Key Players of Urogenital Tract Human Micobiome Table 4. Key Players of Others Table 4. Global Human Microbiome Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Treatment Table 6. Key Players of Diagnosis Table 7. Global Human Microbiome Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Human Microbiome Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Human Microbiome Market Share by Region (2021-2026) Table 10. Global Human Microbiome Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Human Microbiome Market Share by Region (2027-2032) Table 12. Human Microbiome Industry Trends Table 13. Human Microbiome Industry Drivers Table 14. Human Microbiome Industry Opportunities and Challenges Table 15. Human Microbiome Industry Restraints Table 16. Global Human Microbiome Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Human Microbiome Revenue Market Share by Company (2021-2026) Table 18. Global Human Microbiome Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Human Microbiome Key Company Head Office and Area Served Table 20. Global Human Microbiome Company, Product Type & Application Table 21. Global Human Microbiome Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Human Microbiome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Human Microbiome Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Human Microbiome Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Human Microbiome Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Human Microbiome Revenue Market Share by Type (2021-2026) Table 28. Global Human Microbiome Revenue Market Share by Type (2027-2032) Table 29. Global Human Microbiome Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Human Microbiome Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Human Microbiome Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Human Microbiome Revenue Market Share by Application (2021-2026) Table 33. Global Human Microbiome Revenue Market Share by Application (2027-2032) Table 34. Vedanta Company Information Table 35. Vedanta Business Overview Table 36. Vedanta Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Vedanta Human Microbiome Product Portfolio Table 38. Vedanta Recent Development Table 39. Seres Therapeutics Company Information Table 40. Seres Therapeutics Business Overview Table 41. Seres Therapeutics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Seres Therapeutics Human Microbiome Product Portfolio Table 43. Seres Therapeutics Recent Development Table 44. Second Genome Company Information Table 45. Second Genome Business Overview Table 46. Second Genome Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Second Genome Human Microbiome Product Portfolio Table 48. Second Genome Recent Development Table 49. Rebiotix Company Information Table 50. Rebiotix Business Overview Table 51. Rebiotix Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Rebiotix Human Microbiome Product Portfolio Table 53. Rebiotix Recent Development Table 54. ActoGeniX Company Information Table 55. ActoGeniX Business Overview Table 56. ActoGeniX Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. ActoGeniX Human Microbiome Product Portfolio Table 58. ActoGeniX Recent Development Table 59. Enterome BioScience Company Information Table 60. Enterome BioScience Business Overview Table 61. Enterome BioScience Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Enterome BioScience Human Microbiome Product Portfolio Table 63. Enterome BioScience Recent Development Table 64. AvidBiotics Company Information Table 65. AvidBiotics Business Overview Table 66. AvidBiotics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. AvidBiotics Human Microbiome Product Portfolio Table 68. AvidBiotics Recent Development Table 69. 4D Pharma Research Ltd Company Information Table 70. 4D Pharma Research Ltd Business Overview Table 71. 4D Pharma Research Ltd Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. 4D Pharma Research Ltd Human Microbiome Product Portfolio Table 73. 4D Pharma Research Ltd Recent Development Table 74. Enterologics Company Information Table 75. Enterologics Business Overview Table 76. Enterologics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Enterologics Human Microbiome Product Portfolio Table 78. Enterologics Recent Development Table 79. Metabogen Company Information Table 80. Metabogen Business Overview Table 81. Metabogen Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Metabogen Human Microbiome Product Portfolio Table 83. Metabogen Recent Development Table 84. Metabiomics Company Information Table 85. Metabiomics Business Overview Table 86. Metabiomics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Metabiomics Human Microbiome Product Portfolio Table 88. Metabiomics Recent Development Table 89. Ritter Pharmaceuticals Company Information Table 90. Ritter Pharmaceuticals Business Overview Table 91. Ritter Pharmaceuticals Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Ritter Pharmaceuticals Human Microbiome Product Portfolio Table 93. Ritter Pharmaceuticals Recent Development Table 94. Osel Company Information Table 95. Osel Business Overview Table 96. Osel Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Osel Human Microbiome Product Portfolio Table 98. Osel Recent Development Table 99. Symberix Company Information Table 100. Symberix Business Overview Table 101. Symberix Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Symberix Human Microbiome Product Portfolio Table 103. Symberix Recent Development Table 104. Miomics Company Information Table 105. Miomics Business Overview Table 106. Miomics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Miomics Human Microbiome Product Portfolio Table 108. Miomics Recent Development Table 109. Symbiotix Biotherapies Company Information Table 110. Symbiotix Biotherapies Business Overview Table 111. Symbiotix Biotherapies Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Symbiotix Biotherapies Human Microbiome Product Portfolio Table 113. Symbiotix Biotherapies Recent Development Table 114. MicroBiome Therapeutics LLC Company Information Table 115. MicroBiome Therapeutics LLC Business Overview Table 116. MicroBiome Therapeutics LLC Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. MicroBiome Therapeutics LLC Human Microbiome Product Portfolio Table 118. MicroBiome Therapeutics LLC Recent Development Table 119. North America Human Microbiome Market Size by Type (2021-2026) & (US$ Million) Table 120. North America Human Microbiome Market Size by Type (2027-2032) & (US$ Million) Table 121. North America Human Microbiome Market Size by Application (2021-2026) & (US$ Million) Table 122. North America Human Microbiome Market Size by Application (2027-2032) & (US$ Million) Table 123. North America Human Microbiome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Human Microbiome Market Size by Country (2021-2026) Table 125. North America Human Microbiome Market Size by Country (2027-2032) Table 126. Europe Human Microbiome Market Size by Type (2021-2026) & (US$ Million) Table 127. Europe Human Microbiome Market Size by Type (2027-2032) & (US$ Million) Table 128. Europe Human Microbiome Market Size by Application (2021-2026) & (US$ Million) Table 129. Europe Human Microbiome Market Size by Application (2027-2032) & (US$ Million) Table 130. Europe Human Microbiome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Human Microbiome Market Size by Country (2021-2026) Table 132. Europe Human Microbiome Market Size by Country (2027-2032) Table 133. China Human Microbiome Market Size by Type (2021-2026) & (US$ Million) Table 134. China Human Microbiome Market Size by Type (2027-2032) & (US$ Million) Table 135. China Human Microbiome Market Size by Application (2021-2026) & (US$ Million) Table 136. China Human Microbiome Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Human Microbiome Market Size by Type (2021-2026) & (US$ Million) Table 138. Asia Human Microbiome Market Size by Type (2027-2032) & (US$ Million) Table 139. Asia Human Microbiome Market Size by Application (2021-2026) & (US$ Million) Table 140. Asia Human Microbiome Market Size by Application (2027-2032) & (US$ Million) Table 141. Asia Human Microbiome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Human Microbiome Market Size by Country (2021-2026) Table 143. Asia Human Microbiome Market Size by Country (2027-2032) Table 144. South America, Middle East & Africa Human Microbiome Market Size by Type (2021-2026) & (US$ Million) Table 145. South America, Middle East & Africa Human Microbiome Market Size by Type (2027-2032) & (US$ Million) Table 146. South America, Middle East & Africa Human Microbiome Market Size by Application (2021-2026) & (US$ Million) Table 147. South America, Middle East & Africa Human Microbiome Market Size by Application (2027-2032) & (US$ Million) Table 148. South America, Middle East & Africa Human Microbiome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. South America, Middle East & Africa Human Microbiome Market Size by Country (2021-2026) Table 150. South America, Middle East & Africa Human Microbiome Market Size by Country (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Human Microbiome Product Image Figure 2. Global Human Microbiome Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Human Microbiome Market Share by Type: 2025 VS 2032 Figure 4. Gastrointestinal Tract Human Micobiome Image Figure 5. Urogenital Tract Human Micobiome Image Figure 6. Others Image Figure 7. Global Human Microbiome Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Human Microbiome Market Share by Application: 2025 VS 2032 Figure 9. Treatment Image Figure 10. Diagnosis Image Figure 11. Global Human Microbiome Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 13. Global Human Microbiome Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Human Microbiome Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Human Microbiome Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Human Microbiome Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Human Microbiome Revenue Market Share by Type (2021-2032) Figure 20. Global Human Microbiome Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Human Microbiome Revenue Market Share by Application (2021-2032) Figure 22. North America Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 23. North America Human Microbiome Market Share by Type (2021-2032) Figure 24. North America Human Microbiome Market Share by Application (2021-2032) Figure 25. North America Human Microbiome Market Share by Country (2021-2032) Figure 26. United States Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 27. Canada Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 29. Europe Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 30. Europe Human Microbiome Market Share by Type (2021-2032) Figure 31. Europe Human Microbiome Market Share by Application (2021-2032) Figure 32. Europe Human Microbiome Market Share by Country (2021-2032) Figure 33. Germany Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 34. France Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 36. Italy Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 37. Russia Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 39. China Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 40. China Human Microbiome Market Share by Type (2021-2032) Figure 41. China Human Microbiome Market Share by Application (2021-2032) Figure 42. Asia Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 43. Asia Human Microbiome Market Share by Type (2021-2032) Figure 44. Asia Human Microbiome Market Share by Application (2021-2032) Figure 45. Asia Human Microbiome Market Share by Country (2021-2032) Figure 46. Japan Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 50. India Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 51. Australia Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Human Microbiome Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Human Microbiome Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Human Microbiome Market Share by Country (2021-2032) Figure 56. Brazil Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 61. UAE Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 63. Chile Human Microbiome Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Gastrointestinal Tract Human Micobiome
  • Urogenital Tract Human Micobiome
  • Others
Applications
  • Treatment
  • Diagnosis
Companies covered
  • Vedanta
  • Seres Therapeutics
  • Second Genome
  • Rebiotix
  • ActoGeniX
  • Enterome BioScience
  • AvidBiotics
  • 4D Pharma Research Ltd
  • Enterologics
  • Metabogen
  • Metabiomics
  • Ritter Pharmaceuticals
  • Osel
  • Symberix
  • Miomics
  • Symbiotix Biotherapies
  • MicroBiome Therapeutics LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Human Microbiome Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Gastrointestinal Tract Human Micobiome
  5. 1.2.3 Urogenital Tract Human Micobiome
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Human Microbiome Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Treatment
  10. 1.3.3 Diagnosis
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Human Microbiome Growth Trends by Region
  13. 1.5.1 Global Human Microbiome Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Human Microbiome Market Size by Region (2021-2026)
  15. 1.5.3 Human Microbiome Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Human Microbiome Market Dynamics
  1. 2.1 Human Microbiome Industry Trends
  2. 2.2 Human Microbiome Industry Drivers
  3. 2.3 Human Microbiome Industry Opportunities and Challenges
  4. 2.4 Human Microbiome Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Human Microbiome Revenue by Company (2021-2026)
  2. 3.2 Global Human Microbiome Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Human Microbiome Key Company Head office and Area Served
  4. 3.4 Global Human Microbiome Company, Product Type & Application
  5. 3.5 Global Human Microbiome Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Human Microbiome Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Human Microbiome Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Human Microbiome Tier 1, Tier 2, and Tier 3
4 Human Microbiome Market by Type
  1. 4.1 Global Human Microbiome Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Human Microbiome Market Size by Type (2021-2032)
  3. 4.3 Global Human Microbiome Market Size Share by Type (2021-2032)
5 Human Microbiome Market by Application
  1. 5.1 Global Human Microbiome Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Human Microbiome Market Size by Application (2021-2032)
  3. 5.3 Global Human Microbiome Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Vedanta
  2. 6.1.1 Vedanta Company Information
  3. 6.1.2 Vedanta Business Overview
  4. 6.1.3 Vedanta Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Vedanta Human Microbiome Product Portfolio
  6. 6.1.5 Vedanta Recent Developments
  7. 6.2 Seres Therapeutics
  8. 6.2.1 Seres Therapeutics Company Information
  9. 6.2.2 Seres Therapeutics Business Overview
  10. 6.2.3 Seres Therapeutics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Seres Therapeutics Human Microbiome Product Portfolio
  12. 6.2.5 Seres Therapeutics Recent Developments
  13. 6.3 Second Genome
  14. 6.3.1 Second Genome Company Information
  15. 6.3.2 Second Genome Business Overview
  16. 6.3.3 Second Genome Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Second Genome Human Microbiome Product Portfolio
  18. 6.3.5 Second Genome Recent Developments
  19. 6.4 Rebiotix
  20. 6.4.1 Rebiotix Company Information
  21. 6.4.2 Rebiotix Business Overview
  22. 6.4.3 Rebiotix Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Rebiotix Human Microbiome Product Portfolio
  24. 6.4.5 Rebiotix Recent Developments
  25. 6.5 ActoGeniX
  26. 6.5.1 ActoGeniX Company Information
  27. 6.5.2 ActoGeniX Business Overview
  28. 6.5.3 ActoGeniX Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 ActoGeniX Human Microbiome Product Portfolio
  30. 6.5.5 ActoGeniX Recent Developments
  31. 6.6 Enterome BioScience
  32. 6.6.1 Enterome BioScience Company Information
  33. 6.6.2 Enterome BioScience Business Overview
  34. 6.6.3 Enterome BioScience Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Enterome BioScience Human Microbiome Product Portfolio
  36. 6.6.5 Enterome BioScience Recent Developments
  37. 6.7 AvidBiotics
  38. 6.7.1 AvidBiotics Company Information
  39. 6.7.2 AvidBiotics Business Overview
  40. 6.7.3 AvidBiotics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AvidBiotics Human Microbiome Product Portfolio
  42. 6.7.5 AvidBiotics Recent Developments
  43. 6.8 4D Pharma Research Ltd
  44. 6.8.1 4D Pharma Research Ltd Company Information
  45. 6.8.2 4D Pharma Research Ltd Business Overview
  46. 6.8.3 4D Pharma Research Ltd Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 4D Pharma Research Ltd Human Microbiome Product Portfolio
  48. 6.8.5 4D Pharma Research Ltd Recent Developments
  49. 6.9 Enterologics
  50. 6.9.1 Enterologics Company Information
  51. 6.9.2 Enterologics Business Overview
  52. 6.9.3 Enterologics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Enterologics Human Microbiome Product Portfolio
  54. 6.9.5 Enterologics Recent Developments
  55. 6.10 Metabogen
  56. 6.10.1 Metabogen Company Information
  57. 6.10.2 Metabogen Business Overview
  58. 6.10.3 Metabogen Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Metabogen Human Microbiome Product Portfolio
  60. 6.10.5 Metabogen Recent Developments
  61. 6.11 Metabiomics
  62. 6.11.1 Metabiomics Company Information
  63. 6.11.2 Metabiomics Business Overview
  64. 6.11.3 Metabiomics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Metabiomics Human Microbiome Product Portfolio
  66. 6.11.5 Metabiomics Recent Developments
  67. 6.12 Ritter Pharmaceuticals
  68. 6.12.1 Ritter Pharmaceuticals Company Information
  69. 6.12.2 Ritter Pharmaceuticals Business Overview
  70. 6.12.3 Ritter Pharmaceuticals Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Ritter Pharmaceuticals Human Microbiome Product Portfolio
  72. 6.12.5 Ritter Pharmaceuticals Recent Developments
  73. 6.13 Osel
  74. 6.13.1 Osel Company Information
  75. 6.13.2 Osel Business Overview
  76. 6.13.3 Osel Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Osel Human Microbiome Product Portfolio
  78. 6.13.5 Osel Recent Developments
  79. 6.14 Symberix
  80. 6.14.1 Symberix Company Information
  81. 6.14.2 Symberix Business Overview
  82. 6.14.3 Symberix Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Symberix Human Microbiome Product Portfolio
  84. 6.14.5 Symberix Recent Developments
  85. 6.15 Miomics
  86. 6.15.1 Miomics Company Information
  87. 6.15.2 Miomics Business Overview
  88. 6.15.3 Miomics Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Miomics Human Microbiome Product Portfolio
  90. 6.15.5 Miomics Recent Developments
  91. 6.16 Symbiotix Biotherapies
  92. 6.16.1 Symbiotix Biotherapies Company Information
  93. 6.16.2 Symbiotix Biotherapies Business Overview
  94. 6.16.3 Symbiotix Biotherapies Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Symbiotix Biotherapies Human Microbiome Product Portfolio
  96. 6.16.5 Symbiotix Biotherapies Recent Developments
  97. 6.17 MicroBiome Therapeutics LLC
  98. 6.17.1 MicroBiome Therapeutics LLC Company Information
  99. 6.17.2 MicroBiome Therapeutics LLC Business Overview
  100. 6.17.3 MicroBiome Therapeutics LLC Human Microbiome Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 MicroBiome Therapeutics LLC Human Microbiome Product Portfolio
  102. 6.17.5 MicroBiome Therapeutics LLC Recent Developments
7 North America
  1. 7.1 North America Human Microbiome Market Size (2021-2032)
  2. 7.2 North America Human Microbiome Market Size by Type
  3. 7.2.1 North America Human Microbiome Market Size by Type (2021-2026)
  4. 7.2.2 North America Human Microbiome Market Size by Type (2027-2032)
  5. 7.2.3 North America Human Microbiome Market Share by Type (2021-2032)
  6. 7.3 North America Human Microbiome Market Size by Application
  7. 7.3.1 North America Human Microbiome Market Size by Application (2021-2026)
  8. 7.3.2 North America Human Microbiome Market Size by Application (2027-2032)
  9. 7.3.3 North America Human Microbiome Market Share by Application (2021-2032)
  10. 7.4 North America Human Microbiome Market Size by Country
  11. 7.4.1 North America Human Microbiome Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Human Microbiome Market Size by Country (2021-2026)
  13. 7.4.3 North America Human Microbiome Market Size by Country (2027-2032)
  14. 7.4.4 North America Human Microbiome Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Human Microbiome Market Size (2021-2032)
  2. 8.2 Europe Human Microbiome Market Size by Type
  3. 8.2.1 Europe Human Microbiome Market Size by Type (2021-2026)
  4. 8.2.2 Europe Human Microbiome Market Size by Type (2027-2032)
  5. 8.2.3 Europe Human Microbiome Market Share by Type (2021-2032)
  6. 8.3 Europe Human Microbiome Market Size by Application
  7. 8.3.1 Europe Human Microbiome Market Size by Application (2021-2026)
  8. 8.3.2 Europe Human Microbiome Market Size by Application (2027-2032)
  9. 8.3.3 Europe Human Microbiome Market Share by Application (2021-2032)
  10. 8.4 Europe Human Microbiome Market Size by Country
  11. 8.4.1 Europe Human Microbiome Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Human Microbiome Market Size by Country (2021-2026)
  13. 8.4.3 Europe Human Microbiome Market Size by Country (2027-2032)
  14. 8.4.4 Europe Human Microbiome Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Human Microbiome Market Size (2021-2032)
  2. 9.2 China Human Microbiome Market Size by Type
  3. 9.2.1 China Human Microbiome Market Size by Type (2021-2026)
  4. 9.2.2 China Human Microbiome Market Size by Type (2027-2032)
  5. 9.2.3 China Human Microbiome Market Share by Type (2021-2032)
  6. 9.3 China Human Microbiome Market Size by Application
  7. 9.3.1 China Human Microbiome Market Size by Application (2021-2026)
  8. 9.3.2 China Human Microbiome Market Size by Application (2027-2032)
  9. 9.3.3 China Human Microbiome Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Human Microbiome Market Size (2021-2032)
  2. 10.2 Asia Human Microbiome Market Size by Type
  3. 10.2.1 Asia Human Microbiome Market Size by Type (2021-2026)
  4. 10.2.2 Asia Human Microbiome Market Size by Type (2027-2032)
  5. 10.2.3 Asia Human Microbiome Market Share by Type (2021-2032)
  6. 10.3 Asia Human Microbiome Market Size by Application
  7. 10.3.1 Asia Human Microbiome Market Size by Application (2021-2026)
  8. 10.3.2 Asia Human Microbiome Market Size by Application (2027-2032)
  9. 10.3.3 Asia Human Microbiome Market Share by Application (2021-2032)
  10. 10.4 Asia Human Microbiome Market Size by Country
  11. 10.4.1 Asia Human Microbiome Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Human Microbiome Market Size by Country (2021-2026)
  13. 10.4.3 Asia Human Microbiome Market Size by Country (2027-2032)
  14. 10.4.4 Asia Human Microbiome Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Human Microbiome Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Human Microbiome Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Human Microbiome Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Human Microbiome Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Human Microbiome Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Human Microbiome Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Human Microbiome Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Human Microbiome Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Human Microbiome Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Human Microbiome Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Human Microbiome Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Human Microbiome Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Human Microbiome Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Human Microbiome Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst